Source:http://linkedlifedata.com/resource/pubmed/id/20716449
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-9-29
|
pubmed:abstractText |
Vasoactive intestinal peptide (VIP) is a well-known anti-inflammatory neuropeptide. The capacity of VIP can be exhibited through inhibiting inflammatory responses, shifting the Th1/Th2 balance in favor of anti-inflammatory Th2 immunity and inducing regulatory T cells (Tregs) with suppressive activity. In addition to pro-inflammatory Th1 response, Th17 are also believed to play important roles in the pathogenesis of rheumatoid arthritis (RA). In this study, we used collagen-induced arthritis (CIA) model in Wistar rats to investigate the role of VIP in the balance of CD4(+) CD25(+) Tregs and Th17 on RA. Data presented here showed that administration of VIP decreased incidence and severity of CIA. Disease suppression was associated with the upregulation of CD4(+) CD25(+) Tregs, downregulation of Th17- and Th1-type response and influence on the RANK/RANKL/OPG system. The results provide novel evidence that the therapeutic effects of VIP on CIA rats were associated with the balance of CD4(+) CD25(+) Tregs and Th17.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD24,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2 Receptor alpha Subunit,
http://linkedlifedata.com/resource/pubmed/chemical/Osteoprotegerin,
http://linkedlifedata.com/resource/pubmed/chemical/RANK Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor Activator of Nuclear...,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoactive Intestinal Peptide
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1090-2163
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Inc. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
265
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
105-10
|
pubmed:meshHeading |
pubmed-meshheading:20716449-Animals,
pubmed-meshheading:20716449-Antigens, CD24,
pubmed-meshheading:20716449-Arthritis, Experimental,
pubmed-meshheading:20716449-Down-Regulation,
pubmed-meshheading:20716449-Interleukin-2 Receptor alpha Subunit,
pubmed-meshheading:20716449-Osteoprotegerin,
pubmed-meshheading:20716449-RANK Ligand,
pubmed-meshheading:20716449-Rats,
pubmed-meshheading:20716449-Receptor Activator of Nuclear Factor-kappa B,
pubmed-meshheading:20716449-T-Lymphocyte Subsets,
pubmed-meshheading:20716449-T-Lymphocytes, Helper-Inducer,
pubmed-meshheading:20716449-T-Lymphocytes, Regulatory,
pubmed-meshheading:20716449-Vasoactive Intestinal Peptide
|
pubmed:year |
2010
|
pubmed:articleTitle |
Regulatory effect of vasoactive intestinal peptide on the balance of Treg and Th17 in collagen-induced arthritis.
|
pubmed:affiliation |
Department of Immunology, Institutes of Medical Sciences, Shanghai Institute of Immunology, Shanghai JiaoTong University School of Medicine, Shanghai, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|